BioSpace News Archive

Business

Ginkgo Bioworks Announces Collaboration with Merck to Improve Active Pharmaceutical Ingredient Manufacturing

Ginkgo Bioworks today announced a collaboration with Merck to engineer up to four enzymes for use as biocatalysts in Merck’s active pharmaceutical ingredient (API) manufacturing efforts.

October 11, 2022
·
5 min read
Biotech Bay

Metagenomi Announces Opening of Manufacturing Facility for its Next Generation CRISPR Gene-Editing Systems and Therapies

Metagenomi announced that it has opened a new, in-house Good Manufacturing Practices facility, based within its 50,000 square foot campus in Emeryville, California.

October 11, 2022
·
3 min read
Genetown

Signifier Medical Technologies Announces Conference Participation at CHEST 2022, Medtrade East and Maryland Sleep Society Annual Scientific Conference

Signifier Medical Technologies LLC (“Signifier” or the “Company”), a Boston-based medical technology company, announced participation in three upcoming medical conferences.

October 11, 2022
·
3 min read
Biotech Beach

Sonendo®, Inc. Announces Second Annual EndoCon®, An Endodontic Conference on Innovation

Sonendo , Inc. today announced its second annual EndoCon , a nationally recognized endodontic conference focused on innovation.

October 11, 2022
·
3 min read
Drug Development

BridgeBio Pharma Announces First Lung Cancer Patient Dosed in Phase 1/2 Trial and US FDA Fast Track Designation for SHP2 inhibitor BBP-398 in Combination with Amgen’s LUMAKRAS® (sotorasib)

BridgeBio Pharma, Inc., (Nasdaq: BBIO) (BridgeBio), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced that the first patient with non-small cell lung cancer (NSCLC) has been dosed in its Phase 1/2 clinical trial of BBP-398.

October 11, 2022
·
10 min read
Pharm Country

Nephros Announces Agreement to Sell Pathogen Detection Systems Business and Preliminary Results for Quarter Ended September 30, 2022

Nephros, Inc. today announced that it has entered into a definitive agreement to sell its Pathogen Detection Systems (“PDS”) business.

October 11, 2022
·
5 min read
Drug Development

Annovis Bio Announces Publication of Phase 2a Clinical Data in The Journal of Prevention of Alzheimer’s Disease

Annovis Bio, Inc. today announced the publication of Phase 2a clinical study data in The Journal of Prevention of Alzheimer’s Disease.

October 11, 2022
·
5 min read
BioMidwest

M6P Therapeutics Presents Novel AAV Gene Therapy Approach for the Treatment of Gaucher Disease at the ESGCT 29th Annual Congress

M6P Therapeutics Presents Novel AAV Gene Therapy Approach for the Treatment of Gaucher Disease at the ESGCT 29th Annual Congress.

October 11, 2022
·
4 min read
Business

ChromaDex and Nestlé Health Science Announce New Niagen® Commercial Supply Agreement and $5 Million Investment

ChromaDex and Nestlé Health Science Announce New Niagen ® Commercial Supply Agreement and $5 Million Investment.

October 11, 2022
·
6 min read
Pharm Country

Marinus Pharmaceuticals Announces Multiple Presentations at Upcoming Medical Meetings

Marinus Pharmaceuticals, Inc. today announced that four abstracts have been accepted for poster presentation at upcoming medical meetings in October.

October 11, 2022
·
2 min read